1. Abstract Book for the 27th Congress of the European Hematology Association. (23rd June 2022) Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abstracts from the Argentinian Society of Osteology and Mineral Metabolism (AAOMM) and Argentinian Society of Osteoporosis (SAO) 2021 Annual Meeting. (2nd December 2022) Journal: JBMR plus Issue: Volume 6(2022)Supplement 3 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1000: INCREASED PLASMA LEVELS OF LNCRNAS ARE POTENTIAL PROGNOSTIC BIOMARKERS IN MYELOFIBROSIS. (23rd June 2022) Authors: Sartini, S.; Fantini, S.; Rontauroli, S.; Mirabile, M.; Bianchi, E.; Badii, F.; Maccaferri, M.; Guglielmelli, P.; Ottone, T.; Palmieri, R.; Genovese, E.; Carretta, C.; Parenti, S.; Mallia, S.; Tavernari, L.; Salvadori, C.; Gesullo, F.; Maccari, C.; Zizza, M.; Grande, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 890 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1001: DNMT3A/TET2/ASXL1 MUTATIONS DETERMINE THROMBOTIC RISK IN POLYCYTHAEMIA VERA. (23rd June 2022) Authors: Segura Diaz, A.; Stuckey, R.; Florido Ortega, Y.; Sobas, M.; Álvarez Larrán, A.; Ferrer-Marín, F.; Pérez Encinas, M.; Carreño, G.; Fox, M.; Tazón Vega, B.; Cuevas, B.; López Rodriguez, J.; Farías Sánchez, N.; Bilbao Sieyro, C.; Gómez Casares, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1002: ANTI-FIBROTIC ACTIVITY OF BMP2 IN BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS OF MYELOPROLIFERATIVE NEOPLASMS. (23rd June 2022) Authors: Subotički, T.; Živković, E.; Mitrović Ajtić, O.; Vukotić, M.; Đikić, D.; Dragojević, T.; Šefer, D.; Bižić, S.; Santibanez, J. F.; Gotić, M.; Čokić, V. P. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 892 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P1003: PERIPHERAL BLOOD CYTOTOXIC T CELLS SHOW EARLY EXHAUSTED FEATURES IN MYELOFIBROSIS PATIENTS. (23rd June 2022) Authors: Tavernari, L.; Rontauroli, S.; Maccaferri, M.; Mora, B.; Bianchi, E.; Parenti, S.; Genovese, E.; Guglielmelli, P.; Carretta, C.; Mallia, S.; Mirabile, M.; Sartini, S.; Colasante, C.; Potenza, L.; Passamonti, F.; Tagliafico, E.; Luppi, M.; Vannucchi, A. M.; Manfredini, R. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 893 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P1004: EFFECT AND MOLECULAR MECHANISM OF TQ05105, A NOVEL SMALL MOLECULE INHIBITOR OF JAK2 IN MYELOPROLIFERATIVE NEOPLASM. (23rd June 2022) Authors: Zhang, W.; Liu, J.; Shi, Z.; Yang, L.; Li, B.; Xiao, Z. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 894 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P1005: A PHASE 1, OPEN-LABEL, DOSE-ESCALATION STUDY OF SELINEXOR PLUS RUXOLITINIB IN PATIENTS WITH TREATMENT-NAÏVE MYELOFIBROSIS. (23rd June 2022) Authors: Ali, H.; Kishtagari, A.; Maher, K.; Mohan, S.; Mazumder, A.; Chamoun, K.; Karasik, I.; Sbar, E.; Dugom, L.; Tamir, S.; Wang, X.; Prchal, J.; Tantravahi, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 895 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P1006: NEXT GENERATION SEQUENCING (NGS) IN PEDIATRIC MASTOCYTOSIS. (23rd June 2022) Authors: Angi, A.; Bianchi, S.; Palumbo, G.; Filipponi, V.; Rousseau, M.; Moleti, M. L.; Giona, F. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 896 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P1007: PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B IN JAPANESE PATIENTS WITH POLYCYTHEMIA VERA. (23rd June 2022) Authors: Kirito, K.; Edahiro, Y.; Ohishi, K.; Gotoh, A.; Takenaka, K.; Shibayama, H.; Shimizu, T.; Usuki, K.; Shimoda, K.; Ito, M.; VanWart, S. A.; Zagrijtschuk, O.; Qin, A.; Kawase, H.; Miyachi, N.; Sato, T.; Komatsu, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗